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INTRODUCTION 
Cytokinins were first discovered as cytokinetic factors in tobacco 
pith tissue (Jablonski and Skoog, 1954). Cytokinins are basically 
N6-isopentenylated adenine derivatives and have been arbitrarily defined 
as compounds that stimulate cell cytokinesis and growth in certain plant 
tissues (review Kende, 1971). 
The effects of these compounds on plants have been extensively 
studied. Cytokinins are known to influence all stages of plant develop-
ment starting from the initial stages of cell division to the more 
mature stages of organ formation, differentiation and senescence. 
Cytokinins function in plant development in conjunction with other plant 
hormones such as auxins and gibberellins. 
Apical dominance, a phenomenon seen in plants by which the growth 
and development of terminal buds are favored over that of lateral buds, 
can be removed by cytokinins (Wickson and Thimann, 1956). Evidence 
abounds to show that cytokinins also promote the process of flowering 
and fruit development (Werdell and Skoog, 1969; Negi and Olmo, 1966; 
Van Overbeek, 1968: Tepfer et~., 1966). 
Cytokinins are also known to occur in bacteria and fungi that are 
parasitic or symbiotic in plants. Corneybacterium fascians causes a 
disease in plants called witches broom. This disease is characterized 
by the formation of swollen internodes and a release from apical 
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dominance. Thimann and Sachs (1966) were able to duplicate the symptoms 
of fasciation by application of cytokinins to the plants. Armstrong and 
his co-workers (1976) have successfully isolated and identified the 
cytokinin present in the Corneybacterium fascians filtrate. The same 
phenomenon is also seen in the formation of nodules in legumes by 
Rhizobium. Phillips and Torrey (1970) were able to show the presence of 
cytokinins in the Rhizobium species. Agrobacterium tumefacians causes 
crown gall disease in plants and the tumor tissue of the infected plants 
contains high levels of cytokinins (Miller, 1975). 
Cytokinins stimulate the activity of many different enzymes, one 
of which is nitrate reductase (Hirshberg et~·, 1972). In some cases 
they are also known to decrease enzyme activity (Martin and Thimann, 
1972; Birmingham and Mclachlan, 1972; Shibaoka and Thimann, 1970). 
Several studies have also shown that cytokinins stimulate the formation 
of polyribosomes (Short et~., 1974; Tepfer _et~., 1975; Muren and 
Fosket, 1977). In addition to stimulation of protein and RNA synthesis, 
cytokinins also cause an increase in DNA synthesis. Metabolism, 
respiration and biosynthesis of growth factors are also influenced by 
cytokinins in plants. The effect of cytokinins is not merely restricted 
to plant cells. Mammalian cells have also been shown to respond to 
cytokinins, though it is not known that these effects are related 
directly to those seen in plants. These compounds have been found to 
play a role in the inhibition of platelet aggregation (Kikugawa et~., 
1973). Groytth of tumor cells was al so inhibited by cytokinins in 
several in vivo and in vitro studies (Fleysher et~., 1968; Fleysher, 
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1972; Rathbone and Hall, 1972; Grindley et~·, 1973). Cytokinins can 
also act as immunosuppresive agents (Hacker and Feldbush, 1969). These 
plant hormones also competitively inhibit beef heart cyclic AMP 
phosphodiesterase and glucose-6-phosphate dehydrogenase (Hecht et~·· 
1974). In cultured fibroblasts, cytokinins induce cell elongation, 
decrease cell motion and increase cell adhesion to the substratum 
(Johnson et~ .• 1974). N6-( .6. 2-isopentenyl) adenosine (i 6A), a potent 
cytokinin, and several other cytokinins have been found to both 
stimulate and inhibit the growth of phytohemagglutinin - treated human 
lymphocyte cells depending upon the stage of cell cycle at which the 
cytokinin was administered (Gallo et~·· 1972). These workers also 
speculated that cytokinins are involved with cyclic AMP metabolism, 
based on the observation that cyclic AMP exerted similar effects on 
lymphocytes. 
Cytokinins are generally N6-substituted adenine derivatives and 
high cytokinin activity is limited to N6-monosubstituted compounds. 
Basically the structure of cytokinins exhibiting high order activity is 
made up of an intact adenine molecule with N6-substituted side chain of 
moderate size. Substitution of the nitrogen atom at the N6-position 
with either O or S leads to a loss of over 90% in cytokinin properties 
(Skoog et~·· 1967). Modification in the adenine moiety also causes a 
dramatic decrease in cytokinin activity though the question of whether 
adenine itself has cytokinin activity has not been resolved (review 
Skoog and Armstrong, 1970). 
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The nature of the side chain affects the cytokinin activity of the 
molecule. Using 6-n-alkyl-aminopurines (Skoog et~·· 1967), it was 
found that the cytokinin activity of the compound increases with each 
additon of C atoms to the side chain up to an optimum of five C atoms. 
unsaturation in the side chain also confers maximum activity. This can 
be seen in two potent cytokinins, i 6A and zeatin, both of which have 
unsaturation of the side chains. The saturated counterparts show a 
ten-fold decrease in activity. The isopentenyl group as a side chain is 
generally the best for conferring high cytokinin activity to the com-
pound, though ring substituents such as the benzyl ring or furfuryl ring 
are also effective. Studies have failed to determine the presence of 
any specific chemical group that is necessary for activation of the 
cytokinin. In general, cytokinins lack structural specificity and will 
tolerate most changes or substitutions in the parental structure and 
still exhibit cytokinin properties. The general consensus, therefore, 
is that it is the exogenous quality of the molecule itself rather than 
any specific reactive group that confers cytokinin activity to a 
molecule. 
Several compounds of non-purine derivatives have also been found 
to have cytokinin activities; the most important of which are the 
phenylurea derivatives. First demonstrated to show cytokinin activity 
by Steward and Shantz (1956), phenylurea derivatives satisfy the basic 
minimal requirement for activity. This basic structural requirement, 
the presence of an intact -NH-CO-NH- bridge with a phenyl ring attached, 
is satisfied in phenylurea derivatives. 
Cytokinins can occur freely or bound to specific tRNAs. Free 
cytokinins in general occur mostly in higher plants in the rapidly 
growing tissues such as young fruits, seeds, meristematic region of 
roots, root exudate, autonomous callus tissues, and crown gall tumors 
(review Kende, 1971). They have also been found in certain plant 
pathogens, parasites and symbionts (review Letham and Palni, 1983). 
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The relationship between free cytokinins and cytokinin-bound tRNAs 
has been the focus of several studies. One of the controversies in the 
area is the origin of free cytokinins. Do free cytokinins arise from 
the turnover or degradation of tRNA-bound cytokinin or are they produced 
de~ via a pathway independent of tRNA turnover? Chen and Hall 
(1969) forwarded the model of cytokinins in tRNA as being responsible 
for the maintenance of the proper level of free i 6A in tobacco pith 
tissue. In this model, the cytokinin-bound tRNA is not biologically 
active and only exerts its cytokinin activity upon release from the tRNA 
molecule. In an...'!..!!. vitro study, Armstrong et~., (1976), was able to 
demonstrate the release of the cytokinin from the modified tRNAs and 
rRNAs of tobacco callus using nucleases. An alternate pathway other 
than from tRNA turnover for the production of free cytokinins has been 
suggested from the study of Short and Terry (1972). These workers found 
27 times more free cytokinins than the amount detected in the tRNAs in 
root apices and seedling peas. The implication here is that unless the 
turnover rate of tRNA degradation is extremely high, the free cytokinin 
is obtained via an alternative route. Taya and his co-workers (1978), 
reported the existence of a cytokinin biosynthetic pathway not related 
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to tRNA degradation in D. discoideum. They also showed that 5 1 -AMP i s 
the actual acceptor molecule for the i sopentenyl group: 5'AMP + L\ 2-ipp 
i 6AMP + PPi, i 6AMP -7 .6Ad . i enos1ne + Pi. A study by Laloue and Ha 11 
(1973) yielded evidence suggesting that Rhizopogan rosealus is capable 
of producing free cytokinins by a pathway other than from the tRNA 
degradation. In callus cells of moss sporophytes supplied with radio-
active adenine, ~ labelled cytokinin with the same chromatographic 
properties as N6- ( 6. 2-isopentenyl) adenine was found. No radioactive 
cytokinin, however, was found in the tRNA of the callus cells, suggest-
ing the existence of an alternate pathway for the production of free 
cytokinins. Chen and his co-workers (1976), using tobacco tissue, were 
able to show that the tissue is capable of synthesizing i 6Ade and its 
derivatives from adenine and the adenosine analog. A recent study found 
that two yeast mutants, mod5-1 from S. cerevisiae and sinl-26 from 
S. pombe lacking isopentenylated tRNAs, showed no significant differ-
ences in the levels of free cytokinins present when compared to wild 
type yeasts (Zahareas, 1983). 
Another area of intense debate has been the question of whether 
free cytokinins exert their hormonal response through their presence in 
tRNA. Several studies have shown that free cytokinin can be incorpo-
rated into tRNA. Tobacco callus and soybean tissue requiring cytokinins 
for growth have been found to be capable of incorporating radioactively-
labelled 6-benzylaminopurine into RNAs (Fox and Chen, 1967; Walker and 
Leonard, 1974). Walker and Leonard were able to show that incorporation 
of the cytokinin into the tRNAs involved the intact comp'ound with a 
~ 
level of incorporation of about 1 N6-benzylaminopurine for every 104 
tRNA molecules. 
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Kerde and Tavares (1968) used t-benzylamino-9-methylpurine to show 
that inhibition of incorporation into RNA did not affect biological 
activity of the cytokinin in soybean callus tissue. Retarding leaf 
senescence, a known property of cytokinins was found to be unreleated to 
incorporation of the free cytokinin into tRNA (Richmond et al., 1970). 
Certain cytokinins, because of their structural features, are not likely 
to be incorporated into tRNA, and as yet are still thought to be capable 
of exerting hormonal activity (Skoog et al., 1973). The evidence above 
shifted the focus of attention away from tRNAs as the site of free 
cytokinin action. 
The mystery surrounding the mode of action of cytokinins has not 
been unravelled, though the discovery of proteins that specifically bind 
cytokinins has opened a promising line of investigation. Berridge and 
his co-workers (1970) first reported cytokinin binding to 83 s ribosomes 
in Chinese cabbage. Cytokinin binding to ribosomes was later also 
reported in wheat germ (Fox and Erion, 1975). These workers also 
detected the presence of two types of binding sites, one of which had a 
high affinity for substances with cytokinin activity and readily washed 
from the ribosomes with 0.5 M potassium chloride. A positive correla-
tion was found between the extent of binding and the activity of various 
cytokinins, cytokinin analogues and purine derivatives (Berridge et~·· 
1970; Fox and Erion, 1975). A more recent study showed that the 
cytokinin-binding protein in wheat germ ribosomes had a molecular weight 
of approximately 140,000 daltons with three subunits of 54,000, 50,000 
and 40,000 daltons. This cytokinin-binding protein is found to be 
specific for s?me N6-substituted adenines that exhibit cytokinin prop-
erties with the exception of zeatin or other hydroxylated derivaties 
(Erion and Fox, 1977). 
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Polya and Bowman (1979) presented evidence against a receptor role 
for this protein. They found that cytokinin-binding proteins had 
considerable affinity for a number of non-purine compounds, an unlikely 
trait for a hormone receptor, since one expects a receptor to recognize 
a limited set of structural determinants. The authors in turn suggested 
a catalytic function and a cytokinin sequestering function as a more 
plausible role for the proteins. 
Cytokinins, as mentioned earlier, also occur as minor components 
of certain species of tRNA. Cytokinin-active ribonucleosides have been 
found in the tRNA or virtually all organisms tested (Hall, 1970). The 
presence of isopentenyladenosine is apparently universal, and so far it 
is the only cytokinin found in animals. Sequence analyses have detected 
the presence of only one cytokinin base per molecule of tRNA (Barrel and 
Clark, 1974). The modified base is normally found adjacent to the 3' 
end of the anticodon. Cytokinin modified tRNAs occur strictly in the 
species of tRNAs which decode codons starting with U. In E.coli, all 
tRNA species which correspond to codons starting with U have been found 
to contain a cytokinin (Armstrong et~·· 1969; Nishimura et~·· 1969; 
Yamada et~·· 1971). In animal tRNAs tested, Skoog and Armstrong 
(1970) found cytokinin modified bases only in serine tRNA species. In 
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yeasts, the tRNA species containing cytokinin bases are those that code 
for serine (Zachau et~-· 1966), tyrosine (Madison and Kung, 1967) and 
cysteine (Armstrong, et~-· 1969). Base Y has also been found in yeast 
and wheat germ phenylalanine tRNA, occuring in the position adjacent to 
the anticodons on the 31 end (Dudeck et~·· 1969; RajBhandary et~-· 
1967). Acid-promoted excision of Base Y from yeast and wheat germ 
phenylalanine tRNAs resulted in compounds which showed weak cytokinin 
activity (Hechet, et~-· 1970). 
A number of investigations have examined the role of these 
modified tRNAs in the enhancement of translational efficiency. Fitler 
and Hall (1966) successfully changed the chemical moiety in modified 
yeast-seryl-tRNA using aqueous iodine and found that the loss of i 6A 
interferes with the binding of the seryl-tRNA to the ribosome-messenger 
RNA complex. The acceptance of serine residues though, was not 
affected. Gefter and Russell (1969) isolated three different forms of 
suppressor tyrosine tRNA from E. coli. The tRNAs differed only in the 
extent of modification at the base adjacent to the anticodon. It was 
found that the fully modified tRNAs were most effective in supporting in 
~protein synthesis and ribosome binding. The partially modified 
tRNAs showed a slight reduction in in vitro protein synthesis and 
ribosome binding, whereas the tRNAs with the unmodified residues of 
adenylic acid showed a marked reduction in their ability with respect to 
both processes. Furuichi and Ukita (1970) using bisulfite treatment of 
tRNA to chemically alter the i 6A at the 31 end of the anticodon, yielded 
results similar to those observed by Gefter and Russell (1969). 
Faulkner and Uziel (1971) found a reduction in the ability of iodine-
modified phenylalanine tRNA from E. coli to function in in vitro 
polyphenylalanine synthesis. 
On the other hand, the results of the following two studies 
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suggested non-involvement of the modified nucleotides in protein syn-
thesis. Litwack and Peterkofsky (1971) prepared tRNA from a mevalonate-
requiring mutant of Lactobacillus that was 50% deficient in i6A by 
limiting mevalonic acid concentration. The i 6A deficient tRNAs when 
compared with fully isopentenylated tRNA showed no distinguishable 
differences in aminoacylation and ,in vitro protein synthesis. Another 
study using Mycoplasma phenylalanine tRNA, in which the nucleoside next 
to the anticodon is not hypermodified, and a fully modified E. coli 
phenylalanine tRNA, found no difference in the efficiencies of both 
species of tRNA in in vitro protein synthesis (Kimball and Soll, 1974). 
The authors suggested that subtle interactions that are lost under 
in vitro conditions might exist. 
Modified nucleotides have been shown to have a pronounced effect 
on anticodon - anticodon interactions (Grosjean et~·· 1976). Using 
yeast phenylalanine tRNA and E. coli glutamine tRNA, which have 
complementary anticodons, these workers found that modified nucleotides 
play an important role in stabilizing anticodon - anticodon interac-
tions. Studies have also indicated the importance of modified bases 
adjacent to anticodons in specificity of codon recognition (Gefter and 
Russell, 1968; Parthasarathy, 1974). Yarus (1982) formulated a theor-
etical framework of the extended anticodon whereby the loop and stem 31 
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to the anticodon is employed to enhance the accuracy of selected pairing 
with the appropriate codons. _!!!.vivo studies by Laten et~·· (1978) 
and Janner et..!!_., (1980) found a correlation between a decreased sup-
pression efficiency in mutant yeasts and a lack of isopentenylated 
tRNAs. E. coli strains with a mia A mutation (which results in a loss 
of i6A in tRNA) showed reduced efficiency of suppression of UAG and UGA 
nonsense mutations and reduced readthrough levels of UAG and UGA termin-
ation codons (Petrullo et~·· 1983). UAA suppressors and readthrough 
of UAA were unaffected, leading the authors to conclude that the mia A 
mutation is itself a UAA. 
The isopentenyl group of cytokinins is derived from mevalonate. 
Using radioactively labelled mevalonate, N6-( .6. 2-isopentenyl) adenosine 
nucleotide has been identified as one of the products derived from 
mevalonic acid (Chen and Hall, 1969; Fittler et~·· 1968; Peterkofsky, 
1968). Several studies (Chen, 1958; Bloch et~·, 1959; Bloch, 1965) 
have elucidated the pathway from mevalonic acid to sterols and other 
compounds made up of isoprene units (Fig. 1). Mevalonic acid is 
converted enzymatically to a series of intermediates through which .6.. 2-
i sopentenyl pyrophosphate ( A 2-i pp) is produced (Chen, 1962). .6. 2-i pp 
is the immediate precursor of N6-( A 2-isopentenyl) adenosine nucleotide 
in the cytokinin modified tRNAs (Fittler et~ .• 1968; Kline et~ .• 
1969) . .6. 2-i pp: tRNA ~ 2-i so pen tenyl transferase is the enzyme respon-
sible for the transfer of 1:::,. 2-ipp to the specific adenosine residue in 
tRNA. This enzyme has been partially purified from yeast and rat liver 
tissue (Kline et~ .. 1969) and E. coli (Rosenbaum and Gefter, 1972). A 
crude enzyme system was also extracted from tobacco pith tissue that 
catalyzes the attachment of !:!. 2-ipp to an adenosine residue on the 
performed tRNA (Chen and Hall, 1969). The immediate precursor of 
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b. 2-ipp is L::i.3-ipp (Fig. 2). 6.. 3-isopentenylisomerase is the enzyme 
responsible for the catalytic conversion of 6.3-ipp to D..2-ipp. 
A mutant of Saccharamyces cerevisiae, mod 5-1 has been isolated 
and found to contain only 1.5% of the normal tRNA complement of i 6A 
(Laten et~·· 1978). Also incorporated in this strain was an adenine 
dependent UAA nonsense mutation, ade 2-1, and an efficient UAA nonsense 
suppressor, SUP7-o. The partial loss of suppressor function in mod 5-1 
makes the yeast strain adenine-dependent. This trait enables one to 
distinguish the mutant phenotypically from the wild type since the 
accumulation of adenine metabolites confers a pinkish coloration to the 
mutant colonies. 
The lack of isopentenylated tRNAs in this mutant is a result of 
the absence of an effective gene product. The purpose of this study is 
to identify the missing product in mod 5-~ in order to shed more light 
on the nature of the mutation and its feasibility as a useful tool for 
the study of modified tRNAs. 
STATEMENT OF PROBLEM 
An antisuppressor mutant of Saccharomyces cerevisiae or baker's 
yeast, designated as mod5-1 was isolated and found to contain only 1.5% 
of the normal tRNA complement of i6A (Laten et al., 1978). The under-
modification of the tRNAs in mod5-1 is a result of the absence of a 
nuclear gene product, and this study attempts to identify the missing 
gene product. Since isopentenylation of tRNA is the end product of a 
series of enzymatic reactions (Fig. 2), the mutant is most likely 
defective in one of these reactions. The defective enzyme is most 
likely the last enzyme in the pathway, .c:::. 2-isopentenyl -b.2-ipp: 
isopentenyltransferase. A defect in enzymes further upstream should be 
more deleterious to the mutant since the production of other key end-
products will be affected. The mutation as such, has very little effect 
on the cell other than reducing suppressor efficiency. Growth of 
mutants in both complex media and simple media at moderate (28°C) and 
elevated (37°C) temperatures did not differ significantly from the 
nonmutants; little difference in generation times and cell yields was 
seen (Laten et~·· 1978). The second most likely candidate for the 
defective enzyme in this mutant is isopentenylpyrophosphate isomerase, 
which is just one step upstream of ~2-ipp:tRNA-isopentenyl-transferase 
in the pathway for the production of isopentenylated tRNAs. 
13 
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In this study, assays for isopentenylpyrophosphate isomerase and 
isopentenylpyrophosphate transferase activities were carried out. In 
the isomerase assay, radioactive .6.3-ipp was used to monitor the abili-
ties of crude yeast enzyme extracts from mod5-1 and wild type yeasts to 
convert 6 3-ipp to ..6. 2-ipp. In the transferase assay, radioactive 
t:,. 3-ipp was again used, this time to monitor the~ vitro incorporation 
of isopentenylpyrophosphate into mod5:.!. tRNAs using crude yeast enzyme 
preparation from both the mod5-l strain and the wild type strain. 
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Fig. 1 The pathway of sterol biogenesis. 
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MATERIALS AND METHODS 
Yeast Cells 
Yeast cells were grown in liquid YEPD media (1% yeast extract, 2% 
0 peptone and 2% dextrose) at 30 C. The cells grown to an absorbance of 
2.0 - 3.0 at 625 nm, were centrifuged at 5900.[ for 15 minutes, washed 
with distilled water and then harvested by recentrifugation. 
The cells were stored frozen and used as needed. 
Isolation of tRNA 
1 ml of buffer A (0.04 M imidazole - HCl, pH 7.0, 0.1 M NaCl, 
0.01 M MgC1 2 and 0.1 mM EDTA) and 1 ml of buffer-saturated phenol were 
added per gram wet weight of frozen yeast cells. The mixture was 
agitated for 1 hour and the phases separated by centrifugation. The 
aqueous phase was then re-extracted with an equal volume of phenol. 
NaCl was added to the aqueous phase after the second extraction, to a 
final concentration of 0.2M. Two volumes of ice cold ethanol were then 
added and the suspension was stored overnight at -20°c to precipitate 
the nucleic acids. After centrifugation at 12,000.[, the precipitate was 
dissolved in a volume of buffer A corresponding in ml to about half the 
original wet weight in grams of the cells. The sample was then loaded 
on a pre-equilibrated DEAE cellulose column and fractionated by a step 
gradient of NaCl and urea. The first buffer used in the fractionation 
process was buffer A. The second buffer, B, contained 0.04 M imidazole 
16 
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_ HCl, pH 7.0, 0.3 M NaCl, 0.01 M MgC1 2 and 0.1 mM EDTA. The optical 
density of the eluents was monitored at 260 nm. Peaks of increased 
optical density were seen in fractions collected from buffers A and B. 
The absorbance of the washes from both buffers were allowed to level to 
o.Ol A260 units before a change of buffer was made. The last buffer, 
used to elute the tRNA from the column, contained 0.04 M imidazole -
HCl, pH 7.0, 1.0 M NaCl, 4M Urea, 0.01 M MgC1 2 and O.lmM EDTA. All 
fractions with an absorbance of greater than 0.5 at 260 nm, were pooled 
and precipitated with two volumes of cold ethanol. The preparation was 
stored at -20°c. 
Preparation of Crude Yeast Enzyme Extract 
Yeast cells were either lysed with toluene (Laten, 1978) or 
mechanically disrupted with glass beads. In the first method of cell 
lysis, 100 ml of ice cold toluene was added to 50g of frozen yeast 
cells. The yeast paste was allowed to soften, after which the sus-
pension was frozen in dry ice for 2 hours. Excess toluene was poured 
off and the frozen paste was allowed to thaw overnight at 4°C. 2 ml of 
2 M TRIS was added to the thawed suspension. In the second method, 
using the bead beater (Biospec Products) for cell disruption, 2 M TRIS 
was added to the yeast paste in the proportion of 2 ml TRIS per gram wet 
weight of cells. The cells were homogenized in 1 minute intervals for a 
total of 3 minutes. 
Following breakage by either method as described above, the 
homogenate was centrifuged for 20 minutes at 30,000g. The supernatant 
was recentrifuged for another 10 minutes at 30,000g. The supernatant 
was then dialyzed exhaustively against 0.02 M TRIS - HCl, pH 7.5, 
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o.3 M KCl, 0.01 M MgC1 2 and 0.1 mM EDTA. The preparation was then 
concentrated by ultrafiltration (Immersible CX-10), and stored in 0.5 ml 
or 1.0 ml aliquots at -20°c. 
Preparation of Enzyme Extract Enriched for Isopentenylpyrophosphate: 
tRNA isopentenyl transferase 
Initially yeast cells were disrupted by grinding with a mortar and 
pestle and alumina. lOg of alumina was added to lOg of frozen yeast 
paste and ground for about 30 minutes. 10 ml of buffer D (0.05 M TRIS -
HCl, pH 7.5, 0.005 M MgC1 2, 0.02 M mercaptoethanol) were slowly added to 
the yeast suspension during the grinding process. The yeast suspension 
was centrifuged at 30,000g for 20 minutes. The supernatant was recen-
trifuged an additional 10 minutes at 30,000J!.. The enrichment process 
from this point on, parallels the enzyme preparation of Kline et~­
(1969). The supernatant was brought to 45% saturation with ammonium 
sulfate. The ammonium sulfate (25.Sg/100 ml solution) was stirred in 
the supernatant for 10 minutes at o0c. The precipitate formed was 
removed by centrifugation at 15,000..[ for 20 minutes. To the super-
natant, ammonium sulfate (60%, 9g/100 ml) was added and stirred for 10 
minutes at o0c. The precipitate was separated by centrifugation at 
15 ,0001 for 20 minutes. The pellet was then dissolved in a minimal 
volume of buffer D and dialyzed overnight against 2 liters of the same 
buffer. A total of 3 changes of the dialysis solution was made. The 
enzyme preparation, packed in an ice-bath, was then concentrated using 
millipore ultrafiltration units (Immersible CX-10). Aliquots of the 
enzyme preparation were stored at -20°c. 
In a second method of preparation for an enzyme extract enriched 
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for isopentenyltransferase, the cells were disrupted using a bead-
beater. Yeast pellets were homogenized in an ice-chilled bead beater at 
15 second pulses followed by a 30 second cooling period for a total 
homogenization time of 5 minutes. The homogenate was decanted. The 
glass beads were washed with buffer D and the wash added to the pre-
viously decanted homogenate. The combined extracts were centrifuged at 
15,000.[ for 20 minutes. The pH of the supernatant was checked and 
adjusted to pH 7.5 with 2 N ammonium hydroxide. The supernatant was 
brought to 15% saturation (8.5 g/100 ml) with ammonium sulfate and 
stirred for 10 minutes at o0 c. The precipitate was removed by centrifu-
gation at 15,000..[ for 20 minutes. To the supernatant, ammonium sulfate 
was added (90% saturation, 55.6 g/100 ml) and again stirred for 10 
minutes at o0 c. The precipitate was then collected by centrifugation 
(15,000g for 20 minutes) and dissolved in a minimal volume of buffer D. 
The enzyme was concentrated using a millipore ultrafiltration unit 
(Immersible CX-10). Aliquots of the enzyme prepar-ation were stored at 
-20°c. 
Assay for Isopentenylpyrophosphate Isomerase Activity 
The isomerase assay was a modification of the assay used by 
Agranoff !.!~· (1960). For the assay, 1.5 _µmoles MgC1 2, 1.0 µmole 
TRIS, pH 8.0, 0.05 µmoles D.. 3-isopentenylpyrophosphate, 0.90 nmole 
[14c] - 1:::, 3-isopentenylpyrophosphate (53 mCi/mmole), 50 µl of crude 
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yeast enzyme extract in a total volume of 500 µl were incubated at 
37°c. [Protein concentrations of enzyme preparations obtained from wild 
type strain were 20 mg/ml and 62 mg/ml for the mod5-1 strain as measured 
by Lowry protein assay (1951)]. 50 µl aliquots were taken at 0, 10, 
30, 60 and 120 minutes. To each aliquot, an equal volume of 6% cold 
trichloroacetic acid was added to destroy the acid labile product and to 
stop further enzymatic reaction. The sample was then extracted with 
440 µ l of ether and centrifuged for 1 minute to separate the two 
phases. The ether layer was removed and 50 µl of the aqueous layer was 
transferred to a 2.4 cm glass fiber disc, allowed to dry and counted by 
liquid scintillation. The glass fiber discs were counted either in a 
xylene base medium (a product of Amersham) or a toluene based scintilla-
tion medium with 4.5g PPO and 0.09g POPOP per liter of toluene. 
Assay for tRNA Isopentenylpyrophosphate: 
tRNA isopentenyl transferase 
The transferase assay was a modification of the assay used by Kline 
!!~. (1969). The mixture for assaying transferase activity contained 
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75 µmoles of TRIS-HCl, pH 7 .5, 9 µmoles of MgC1 2, 3 µmoles of f3 -
mercaptoethanol, 45 nmoles of [ 14cJ- ~ 3-isopentenylpyrophosphate, 
crude yeast enzyme extract (5 mg protein), mod5-1 tRNA (30 O.D. units), 
enriched enzyme preparation (30 mg) in a total volume of 1.5 ml. 
The initial reaction mixture (without tRNA and enriched enzyme 
preparation) was incubated at 37°C for 45 minutes to allow for the 
conversion of 6. 3-i sopentenyl pyrophosphate to b. 2-i sopentenyl pyrophos-
phate. Two aliquots, 50 µl each, were taken at O and 30 minutes to 
monitor the isomerase activity. mods~1 tRNA and the enriched enzyme 
preparation were then added to the incubated mixture in a final volume 
of 1.5 ml. At various times, 300 µ.l aliquots were removed from the 
incubation mixture and immediately immersed in ice to stop the reaction. 
Samples were then loaded onto pre-equilibrated DEAE cellulose columns 
made from Pasteur pipettes (length of column was 6 cm). The tRNA was 
isolated from the column by a step gradient of NaCl and urea as 
described eariler under "Isolation of mod5-1 tRNA". The columns were 
washed with 20 ml of buffer A and 5 ml of buffer B. 5 ml of buffer C 
were used to elute the tRNA from the column. The tRNA was precipitated 
overnight with 2 volumes of ice-cold ethanol at -20°c. The precipitate 
was isolated by centrifugation at 10,000.[ for 10 minutes, and dissolved 
in 2 ml distilled deionized water. 100 µ l of the sample was placed 
into vials containing 10 ml of Aqueosol and counted by liquid scintilla-
ti on. 
A second modification of the transferase assay used by Kline et~· 
(1969) was made. In this assay, the incubation mixture contained: 40 
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nmoles of [14cJ- 6. 3-isopentenylpyrophosphate, crude yeast enzyme 
extract (0.5 mg protein), tRNA (20 O.D. units), and buffer A in a final 
volume of 2 ml. The mixture was incubated at 37°C. At various reaction 
times, 0, 30, 60, 120 and 240 minutes, 400 pJ of the mixture was 
sampled and placed into pre-chilled vials. The samples were then loaded 
onto pre-equilibrated DEAE cellulose columns and the tRNA eluted from 
the column by a step gradient of NaCl and urea. 10 ml of buffer A, and 
10 ml of buffer B were used to wash the column. The tRNA, eluted with 
buffer C, was collected in one 1.3 ml fraction and four 2.0 ml frac-
tions. Each of these fractions was precipitated overnight with twice 
the volume of cold ethanol at -20°c. The precipitate was collected by 
centrifugation at 15,000_[ for 20 minutes. The precipitate was then 
dissolved in 200 µl of distilled deionized water. 200 µl of the 
dissolved sample was placed into vials containing 5 ml of scintilla-
tion liquid (Ready-Solve EP) and counted by liquid scintillation. 
General 
Cold t:, 3-isopentenylpyrophosphate was a gift of Dr. D. Poulter, 
[ 14cJ- 6.3-isopentenylpyrophosphate with a specific activity of 53 
mCi/mmol e was a product of Amer sham. For the tRNA i sopentenyl trans-
ferase assays, the [ 14cJ- 6.3-isopentenylpyrophosphate used was either 
a product of Amersham (53 mCi/mmole) or New England Nuclear 
(50.4 mCi/mmole). 
Counting of Radioactivity 
All samples were counted in a Packard Tri-Carb 300 liquid scin-
tillation counter. 
Quantitation of Protein 
Quantitation of protein was done using the Lowry protein assay 
(1951). The standard used was bovine serum albumen. 
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FIGURE 2 
MEVALONIC. ACID = ATP 
melvonic 
kinase 
PHOSPHOMEVALONIC ACID + ADP 
(
ATP 
phosphomevalonic 
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/\DP 
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(TP 
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b.. 3 - i PP 
i somerase 
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tRNA 
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ISOPENTENYLATED tRNAs + ppi 
Fig. 2 The pathway from mevalonic acid to isopentenyladenosine. 
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RESULTS AND DISCUSSION 
Determination of Isopentenylpyrophosphate 
Isomerase Activity in Wild Type and Mod5-1 Yeasts 
In the isomerase assay, loss of radioactivity in the aqueous layer 
after the ether extraction is indicative of the amount of conversion of 
l:::. 3-ipp to ~ 2-ipp by the isomerase enzyme present. !::,. 2-ipp is acid 
labile whereas .6 3-ipp is stable in acid. The addition of trichloro-
acetic acid causes the breakdown of the L\ 2-ipp and the ether extracts 
breakdown products from the aqueous layer. Therefore, as conversion of 
~ 3-ipp to ~ 2-ipp progresses, decreasing radioactive counts will be 
observed in the aqueous layer. 
Increasing isomerase enzyme concentration or the reaction time will 
have the same effect of increasing the extent of conversion of b. 3-ipp 
to D.. 2-ipp. Initially, several preliminary assays were done using 
varying concentrations of crude yeast enzyme extract from the wild type 
strain and a constant reaction time. These assays were all modifica 
tions of the assay used by Agranoff et~· (1960}. The incubation 
mixture initially contained 1 nmole [ 14cJ- ~3-ipp (6,000 c.p.m.) in 
10 mM TRIS-HCl, pH 8.0, 15 mM MgC1 2 (buffer E) in a final volume of 
20 µ1. Incubation was at 37°c for 30 minutes. The protein concentra-
tions used, ranged from 0-0.2 mg. The expected results would be an 
observation of decreasing radioactive counts with increasing protein 
concentration. The observed results though, (Table 1), did not reflect 
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this trend. In Assay 1.1, two samples with 50 pg and 100 µg of 
protein showed higher radioactive levels than the sample with no protein 
added. In Assay 1.2, less protein was used, ranging from 0 µg to 33 
p.g. Results were equally inconclusive. The drastic drop in the sample 
containing 16 µg protein was probably due to a sampling error. In 
Assay 1.3, with concentration of protein used ranging from 0 µg to 
8 µ g, only one sample (with 6 µ g of protein), showed less acid stable 
radioactivity level than the sample containing no protein. With the 
exception of the sample containing 0.2 ).lg protein in Assay 1.4, the 
expected trend was observed. The decrease in radioactive counts, 
however, was far less than expected. 
At this point, a slightly different approach was taken. Assays 
were done using a constant enzyme concentration, but sampled at varying 
times. Since all samples were taken from only one reaction mixture, 
this approach minimized errors that might be introduced in aliquoting 
materials for the incubation mixtures. The reaction contained 10 nmoles 
of b. 3-ipp, in buffer E in a final volume of 200 µl. Results are 
summarized in Table 2. The expected pattern of decreasing counts with 
time was not observed. 
The substrate concentration of .6. 3-ipp was next increased. In a 
total volume of 6 µl of buffer E, 1 nm [ 14cJ- ~ 3-ipp (6,000 c.p.m.) 
was incubated with 2 µ.g of wild type yeast enzyme extract. The 
observed results, summarized in Table 3, were not consistent with the 
expected. The assay was repeated with the final volume of buffer E 
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increased to 24 µ.l. The results from this assay were also inconclu-
sive. The minor reductions in substrate radioactivity after 60 minutes 
were of questionable significance. 
We speculated that unacceptable high background levels of radio 
activity from products might be responsible for our inconclusive results 
and accordingly incorporated nonradioactive t:. 3-ipp in the assay. In 
the following assays, sop.moles (0.10 mMolar) of both radioactive and 
nonradioactive 6. 3-ipp was used. The specific activity of [ 14cJ- D. 3-
ipp was reduced from 53 mCi/mmole to 0.10 J-1.Ci/ J-lffiOle in Assay I and 
to 0.95 p..Ci/ µmole in Assays 4.2 - 4.7. Table 4 summarizes the 
results of the assays. The assays all showed significant decreases of 
radioactive counts with time. The results of the assays are also pre-
sented in Figure 3. The specific activity of the isopentenylpyrophos-
phate isomerase, calculated from the initial decrease in substrate, was 
determined for both the wild type and modS-1 enzyme preparation (Table 
4). A unit of isomerase is defined as the amount of enzyme which 
0 
catalyzes the isomerization of 1 nmole of substrate per hour at 37 C. 
The specific activity of ipp isomerase in the wild type calculated from 
Assays 4.1, 4.2, 4.6 and 4.7 ranged from 1.6 units/mg to 13 units/mg. 
The ipp isomerase in mod5-1, calculated from Assays 4.4 and 4.5, gave 
specific activities of 0.87 units/mg and 2.7 units/mg respectively. It 
is clear here that the mod5-1 specific activity of 2.7 units/mg falls 
within the range of the specific activity of the wild type isomerase. 
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With this overlap in range of the specific activities in wild type 
and modS-1, we concluded that the ipp isomerase is functional in the 
modS-1 strain. 
From these results it appears even more likely that b. 2-isopentenyl-
pyrophosphate:tRNA- /:::;. 2-isopentenyl transferase is the enzyme that is 
deficient in modS-1. The isomerase reaction provides the basis for the 
reaction conditions in the transferase assay. In the transferase assay, 
tRNA was added as substrate for the transferase enzyme. -mercaptoe-
thanol, a reducing agent, was also introduced into the reaction mixture. 
Assays 4.6 and 4.7 were compared to determine the effects of -mercap-
toethanol on the isomerase reaction. The wild type enzyme extracts used 
in both assays were from the same batch, and the experiments were 
carried out simultaneously. The isomerase activity with 0.01 mMolar /3 -
mercaptoethanol present (Assay 4.6) was determined to be 3.1 units/mg. 
Without,B -mercaptoethanol, the specific activity as determined from 
Assay VII was 1.6 units/mg. The specific activity of the ipp isomerase 
with mercaptoethanol present was about twice the specific activity of 
the ipp isomerase without the mercaptoethanol. The difference in the 
activities, although of questionable signficance, is interesting 
especially in view of the findings of Sagami and Ogura (1983). They 
were able to separate four isopentenylpyrophosphate isomerases from 
avian liver homogenates using DE-52 cellulose column chromatography, and 
found that 1 mM /3 -mercaptoethanol activated at least two of these 
isomerases. 
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Determination of /;:,. 2-isopentenylpyrophosphate: tRNA- b. 2-isopentenyl 
transferase activity in wild type and modS-1 yeasts 
In the transferase assay, incorporation oft,. 2-ipp into tRNA can be 
monitored by using radioactively labelled £:,.. 3-ipp. ,6. 3-ipp in the 
presence of ipp isomerase is converted to ~ 2-ipp. D. 2-ipp is incor-
porated into tRNA by the action of 6. 2-isopentenylpyrophosphate: 
tRNA- 6 2-i sopentenyl transferase ( tRNA-ipp transferase). Attachment of 
the 6 2-i sopentenyl group occurs on the N6 position of a specific 
adenosine residue of the tRNA (Kline et~-· 1969). 
Several preliminary experiments, all modifications of the trans-
ferase assay used by Bartz et~- (1969), did not give the expected 
results. Using radioactive 6 3-ipp, incorporation of the .D. 2-ipp into 
the tRNA should result in an increase in radioactive tRNA taken from the 
incubation mixture with time. 
In the first trial, 150 µmole of TRIS-HCl, pH 7.5, 30 µ.moles of 
MgC1 2, 30 µmoles of ,8-mercaptoethanol, 30 A260 units of tRNA from 
modS-1, 12 nmoles c14cJ- !J. 3-ipp (78,000 c.p.m.) and 90 mg of crude wild 
type enzyme in a final volume of 3 ml, were incubated at 37°c. Aliquots 
taken at intervals were extracted with phenol and tRNA in the aqueous 
phase was precipitated on glass fiber discs with cold trichloracetic 
acid, washed in ethanol and trichloroacetic acid, and counted. 
Table 5 summarizes the results of the initial transferase assays. 
In Assay 5.1, the increases in radioactive counts at 60 and 90 minutes 
were not significant and background levels were highly variable. 
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In several experiments that followed, various parameters such as 
the subtrates ( 6 3-ipp and tRNA) and enzyme extract concentrations were 
varied. In Assays 5.2, 5.3, and 5.4, the concentration of 6. 3-ipp was 
increased to 13.3 A260Jml, and the enzyme extract used ranged from 
3 to 20 mg. Results were equally inconclusive. The radioactive counts 
in Assay 5.7, a control containing no tRNA, were fairly constant. 
Sampling though was done in triplicate, and too much variation was seen 
within the sets of triplicates for the results to be deemed significant. 
Assays 5.6 and 5.10 showed the expected trend of increasing counts with 
time but were considered inconclusive for the same reason. 
In an attempt to boost the concentration of the tRNA-ipp trans-
ferase enzyme, the crude yeast extract was enriched for tRNA-ipp 
transferase using a modification of the protocol of Kline et~· (1969). 
[See the first method of enriched enzyme preparation in "Materials and 
Methods".] These workers found the transferase activity of the enriched 
preparation to be nine times greater than the crude extract. The 
results of Assays 6.1 - 6.10 are summarized in Table 6. In assays 6.1 
and 6.2, the specific activity and concentration of L'.l3-ipp was 
maintained at 0.95 µCi/ µmole and 0.02 mM respectively. Both crude 
wild type enzyme extract (5 mg) and the enriched preparation (10 mg) 
were used. The results of Assays 6.1 and 6.2 were inconclusive. 
We felt that it was necessary to allow time for the conversion of 
Ll 3-ipp to A 2-ipp before introducing tRNA and the tRNA-ipp transferase 
enriched preparation into the incubation mixture. With this in mind, 
the mixture was incubated at 37°c for 45 minutes prior to addition of 
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tRNA and the enriched enzyme preparation. The isomerase reaction was 
also monitored. For all isomerase reactions monitored, between 70% -
80% conversion of D..3-ipp to .6. 2-ipp was observed within 60 minutes of 
incubation at 37°C. 
Even with the above modifications, the Assays 6.3 and 6.4, did not 
give the expected results. The inconclusiveness of the observed data, 
we felt, was largely due to excessive background. Kline et!}_. (1969), 
encountered similar problems in their attempts to assay the incorpora-
tion of radioactivity into tRNA by precipitation with either perchloric 
acid or trichloroacetic acid. They also found that extensive washing 
and reprecipitation failed to remove the contaminating radioactivity. 
For the next set of assays, a different technique was used to isolate 
the tRNA. Isolation of tRNA was done using DEAE cellulose columns. 
Elution of tRNA was achieved with a step gradient of NaCl and urea as 
described in ''Materials and Methods." The results of Assays 6.5 - 6.10 
are summarized in Table 6. Both the mod5-1 (Assays 6.7 - 6.8) and the 
wild type strain (Assays 6.5, 6.6, and 6.9) showed increases in radio-
active levels relative to the sample taken at O time. However, contrary 
to expectations, the increase in counts was more dramatic in the mod5-1 
strain than in the wild type. In Assay 6.8, monitored for the first two 
hours, an increase in radioactive counts was seen at 45 minutes followed 
by a drastic decrease at 120 minutes for the mod5-1 strain. The wild 
type strain on the other hand (Assay 6.9), showed a steady increase of 
radioactive counts for the same duration of time. Since ipp isomerase 
was found to be functional in mod5-l, the likely candidate for the 
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deficient enzyme in mod5-1 is tRNA-ipp transferase. This being the 
case, incorporation of tRNA should be less dramatic or even non-existent 
in the mod5-1 strain as compared to the wild type. 
One possible explanation for the above contradictory observations 
could be the presence of tRNAs in the enzyme preparations. The wild 
type enzyme extract differed from the mod5-1 enzyme extract in one 
respect; the presence of fully modified tRNAs. The isopentenylation of 
the unmodified tRNAs was possibly inhibited by the presence of fully 
modified tRNAs. Crude mod5-1 enzyme extract preparation on the other 
hand, is not contaminated with fully modified tRNAs. In essence, this 
has the effect of increasing the concentration of the substrate tRNA in 
the incubation mixture. Bartz et~· (1970) using a partially purified 
E.coli enzyme found the incorporation of isopentenyl groups into tRNA to 
be linearly proportional to tRNA concentration. Allowing for the 
presence of some enzymic reaction in mod5-l, the two factors mentioned 
could lead to an observed enhancement of incorporation of b.. 2-ipp in 
mod5-1 relative of the wild type. 
The next set of assays were done using a relatively nucleic acid 
free enriched enzyme preparation. The contaminating tRNA was removed 
from the enriched enzyme preparation by precipitating out the protein 
with ammonium sulfate. (See the second method of enriched enzyme 
preparation in "Materials and Methods.") 
The tRNA, eluted from DEAE cellulose columns with 1.0 M NaCl and 
4.0 M urea, was collected in five different fractions. In nearly all 
cases, the tRNA eluted in the first 3 fractions in Assays 7.1 and 7.6 
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were combined and the results summarized in Tables 7A and 7B. Results 
of Assays 7.1, 7.2, 7.3, and 7.4 are also shown in Figure 4. 
Significant incorporation of the radioactively labelled isopentenyl 
group was seen in the wild type strain (Assays 7.1 and 7.2). Two 
different strains of mod5.1 were used in the transferase assays. Strain 
number 1320 showed no incorporation of the isopentenyl group into the 
tRNA, indicating total absence of transferase activity. Assay 7.4 
(strain number 43) showed very slight incorporation at 30, 60, 240 
minutes and 0 incorporation at 120 minutes. 
A unit of tRNA-ipp transferase was defined as that amount of enzyme 
incorporating 1 pmole of 6. 2-isopentenyl pyrophosphate into 20 A260 
units of tRNA in 1 hour. By this definition, the specific activity of 
the tRNA-ipp transferase for the wild type was 1.4 units/mg for Assay 
7.1 and 0.64 units/mg for Assay 7.2. The specific activity for mod5-1, 
strain number 43 was 0.12 units/mg and O units for strain number 1320. 
The specific activities calculated for tRNA-ipp transferase were the 
result of observations made of two coupled reactions; the conversion of 
6 3-ipp to .6. 2-ipp and the incorporation of the b,. 2-ipp into tRNAs. 
These values we feel can only be accepted as rough approximations. 
In Assays 7.5 and 7.6, the tRNA substrate used was from fission 
yeast. The fission yeast used was a sin 1 mutant that lacked 
isopentenylated tRNAs. In Assay 7.5 using wild type enzyme, generally 
no incorporation was observed (isopentenylation was observed to a small 
degree at 30 minutes). The tRNA-ipp transferase in baker 1 s yeast 
appears incapable of catalysing the isopentenylation of undermodifiea 
T , ~"'''"< -., •' - ' 
.,,j 
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tRNAs in fission yeasts. In Assay 7.6, with mod5-l enzyme, as expected 
no incorporation was observed. The sample tRNA taken at O time, 
however, showed a very high radioactive level. This observation could 
only be attributed to an error, but the nature of this error could not 
be determined. 
In summary, this study suceeded in identifying the missing gene 
product in mod5-l, a yeast mutant lacking isopentenylated tRNAs. It was 
theorized that the missing gene product was probably an enzyme based on 
the fact that the mutation is recessive. The most likely candidate for 
the defective enzyme was ~ 2-isopentenylpyrophosphate:tRNA- 6 2-
isopentenyl transferase. Another possible candidate, although unlikely, 
was isopentenyl pyrophosphate isomerase, the enzyme catalyzing the 
reaction one step upstream in the pathway for the synthesis of 
isopentenylated tRNAs. The results of the isomerase assays indicated 
that the isomerase enzyme was active in mod5-1. However, the trans-
ferase assays revealed that mod5-l lacked transferase activity; showing 
a complete absence of isopentenylation of the tRNAs in one strain of 
mod5-l and marginal activity in another when compared to the wild type. 
We concluded that our initial hypothesis was correct; the£::,.. 2-
isopentenylpyrophosphate:tRNA- ~ 2-isopentenyl transferase was indeed 
the deficient gene product in mod5-1. 
tRNA-ipp transferase does not appear to play a vital role in 
yeasts. Isopentenylation is not required for growth in yeasts, with the 
mod5-l mutation showing no effect on growth of the mutants. The growth 
of the mutants showed little difference from the wild type in terms of 
cell yields and generation time (Laten et~·· 1978). 
35 
The effect on protein synthesis~ vivo is quite subtle and 
requires sensitive monitoring based on antisuppression. Despite the 
fact that this enzyme and its product appear to be dispensable, they may 
be of great significance when reviewed on evolutionary time scales as 
opposed to laboratory ones. 
TABLE 1 
Amount of protein 0 50 100 150 200 
Assay g 
1 
c.p.m. 37.989 59,943 41,193 31,666 30,072 
Amount of protein 0 6 16 21 33 
Assay g 
2 
c.p.m. 34 .599 22,181 1,536 32. 715 23,064 
Amount of protein 0 2 4 6 8 
Assay g 
3 
c.p.m. 35, 177 35,613 55,015 31,800 57,439 
Amount of protein 0 0.2 0.4 0.8 2.1 
Assay g 
4 
c.p.m. 28,078 20.357 26,399 25,610 21,951 
Assay for isopentenylpyrophosphate isomerase: 
Each assay contained 1 nm[ 14cJ- A 3-ipp, 0.3 µmole MgC1 2, 
0.2 µmole TRIS, ph 8, and distilled deionized water in addition 
to the different concentrations of wild type yeast enzyme extract. 
Incubation was for 30 minutes at 37°C. 
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TABLE 2 
Amount Incubation Time (minutes) 
of 
protein 
( )Ag) 0 30 60 90 120 
2 27,910 22,497 21,787 18,343 22,196 
3 21,599 21,945 24, 716 21,049 20,229 
2 24,270 25,520 27,837 -- 23,854 
(Boiled) 
Assay for isopentenylpyrophosphate isomerase: 
Each assay contained 10 nmoles[ 14cJ- .:".). 3-ipp, 
3 p. moles MgC1 2 0.5 µmoles TRIS, pH 8.0, wild 
type yeast enzyme extract and distilled deionized 
water in a final volume of 200 µl. Incubation 
was at 37°C. Values given are in c.p.m. 
w 
-.....J 
TABLE 3 
Assay Amount Final Incubation Time (minutes) 
of Volume 
Protein ( µ 1) 
( pg) 0 15 60 
( i ) 2 6 3,730 4,413 3,063 
(ii) 4 24 12,983 10 ,469 10,935 
Assay for isopentenylpyrophosphate isomerase: 
(i) Assay contained 1 nmole [ 14cJ- [),. 3-ipp, 0.8 p. mole 
MgC1 2, 0.5 µmole TRIS-HCl, pH 8.0, wild type yeast 
enzyme extract and distilled deionized water. Incu-
bation was at 37°c. 
(ii) Assay contained 4 nmoles [ 14cJ- 6 3-ipp, 3 µmole 
MgC1 2, 2.0 µmole TRIS-HCl, pH 8.0, wild type yeast 
enzyme extract and distilled deionized water. Incu-
bation was at 37°C. 
Values given are in c.p.m. 
w 
CX> 
TABLE 4 
Counts Per Minute 
Assay Pre para ti on Protein Specific Activity (mg) 0 10 30 60 120 ~uni ts/mg)* 
1 ~Enzyme 1.0 304 -- 68 48 31 4.3 
2 ~ Enzyme 1.0 3,328 l,03S 742 622 soo 13 
3 Boiled ~Enzyme 1.0 4,1S9 -- 3,966 4,133 -- 0 
4 ~Enzyme 3.0 l,7S6 308 2S6 222 242 2.7 
s ~Enzyme 3.0 1,872 -- 48S 302 -- 0.87 
6 MODS+ Enzyme 
~Mercaptoethanol 1.0 2,678 2,137 1,264 659 -- 3.1 
7 MODS+ Enzyme 
without Mercaptoethanol 1.0 2,733 2,433 1,460 654 -- 1.6 
Assay for isopentenylpyrophosphate isomerase: 
3 E.\ch assay contained SO µmoles of fl -ipp, 1.5 moles MGC1 2, 1.0 _µmole TRIS-HCl, pH 8.0, crude yeast enzyme extract and 
distilled deionized water in a final volume of SOO µ1. Incubation was at 37°C. 
*A Hnit of isomerase is defined as the amount of enzyme which catalyzes the isomerization of 1 nmole of substrate per hour at 
37 c. 
TABLE 5 
Final 
6 3-ipp 
Mod5-l Counts Per Minute 
Volume tRNA Protein 
Assay (µ1) (mMolar) A260 (mg) 0 min 15 min 30 min 60 min 
1 3000 0.004 30 90 125 140 131 98 
(60 min) (90 min) (120 min) 
2 1500 0.1 20 3 135+34 65+17 42+11 59+ 3 
3 1500 0 .1 20 3 155+38 148+33 113+ 12 77+19 
4 1500 0.1 20 20 154+29 49+ 5 25+ 4 16+ 7 
5 1500 0.02 200 2 348+159 165+37 185+88 161+25 
6 1500 0.02 200 4 95+ 9 108+15 108+18 2R3+71 
7 1500 0.02 0 4 82+24 52+26 82+40 86+104 
8 1500 0.02 200 10 328+15 103+ 6 93+16 103+ 8 
9 1500 0.02 0 10 681+55 --- 819+970 85+16 
10 1500 0.02 200 20 82+31 288+32 236+26 195+ 8 
tRNA - ipp transferase assay: In addition to [ 14cJ - ti 3 - ipp, tRNA, and enzyme extract and each assay contained 0.05 H 
TRIS-HC1, PH 7.5, 0.01 H Mg c1 2 and 0.01 M ,s - Mercaptoethanol. The specific activity of [
14
cJ - I:!.. 3 - ipp in Assays 5.1 
to 5.4 was 53 mCi/nwnole and 0.95 µCi/ f'mole in Assays 5.5 to 5.10. Aliquots taken at intervals were P.xtracted with 
phenol and the tRNA precipitated on glass fiber discs and cold trichloroacetic acid. The discs were washed in ethanol and 
trichloroacetic acid and counted. 
TABLE 6 
A 3-ipp 
modS-1 Protein Counts Per Minute 
tRNA Yeast Extract (mg) 
Assa) (mMolar) A260 Strain Crude Enriched 0 min lS min 30 min 4S min 60 min 120 min 
1 0.02 100 MODS+ s 10 134+ 2 102+6 94+ 0 -- 69+ 6 
--
--
2 0.02 0 0 10 198+13 
-- -- -- 66+,2 --
3 0.03 30 MODS+ 3 3 
--
S67+10 -- 341+94 -- 292+10 
--
4 0.03 30 s 30 l,98S+503 -- 2,655+699 -- 2,653+2,192 --
s 0.03 18 MODS+ 2.S 30 102 
-- -- 239 -- --
·--
6 0.03 30 MODS+ 5 30 128 -- -- 258 -- --
--
7 0.03 30 modS-1 5 30 139 
-- -- 594 -- --
8 0.03 30 modS-1 s 30 417 767 -- 1,011 -- 378 
---
9 0.03 30 MODS+ s 30 
--
SlS S70 -- 628 
-- 740 
10 0.03 30 Boiled 5 30 S53 SS3 -- -- -- 534 
Enzyme 
,____._ 
14 . . 3 
tRNA - ipp transferase assay: Each assay contained [ C] - ~ - ipp, tRNA, enzyme extract, 0.05 M TRIS-HCl, pH 7 .5, 0.01 M 
MgC12 and 0.01 M ~ - Mercaptoethanol 1n a final volume of 1500 µl. The specific activity of the [ 14c] - fl 3 - ipp in Assays 
5.1 and 6.3 were 0.9S µCi/ p.mole and 53 mCi/ntnole in Assays 6.4 to 6.10. Incubi\tion was at 37°C. 
(i) In Assays 6.1 and 6.2, the sampled tRNA was extracted with phenol, precipitated with cold trichloroacetic acid and 
counted. 
(ii) In Assays 6.3 to 6.10, the incubation mixture wi\s allowed to incubate for 45 minutes before the i\ctrtition of tRNA and 
the enriched enzyme preparation. Isolation of tRNA was done using trichloroacetic acid precipitation as described in 
*( i). 
(iii) *In Assays 6.5 to 6.10, the tRNA was isolated using DEAE cellulose columns (See "Materials and Methods"). 
TABLE 7A 
-
Protein Counts Per Minute 
Assay tRNA Yeast Extract (mg) 
Subtrate Strain Crude Enriched 0 Min 30 Min 60 Min 120 Min 
1 mod5-1 MOD5+ 0.5 4 131 288 292 320 
2 mod5-1 MODS+ 0.5 10 80 261 396 --
--- --
---- -
3 mod5-l modS-1 0.5 10 0 0 0 0 
\1320) 
-
4 mod5-1 modS-1 0.5 10 18 50 56 12 
{ 43) 
5 Fission MODS+ 0.5 10 63 125 17 52 
·--
-· 
6 Fission modS-1 0.5 10 866 0 35 0 
( 43) 
tRNA - ipp transferase assay: See "Materials and Methods" for the assay conditions. 
·-
240 Min 
' 
--
--
--
42 
40 
2 
·-
+'> 
N 
Assay 
1 
-· 
2 
3 
4 
5 
6 
TABLE 7B 
Protein !pp incorporated into 20 O.D. Units of tRNA (p moles) 
tRNA Yeast Extract (mg) 
Substrate Strain Crude Enriched O min 
mod5-1 
mod5-1 
mod5-1 
mod5-1 
Fission 
Fission 
-
MOD5+ .5 4 
MOD5+ .5 10 
mod5-1 .5 10 
{ I320) 
I---
mod5-1 .5 10 
{ 43) 
MOD5+ .5 10 
mod5-1 .5 10 
{ 43) 
Transferase Assay: 
!pp incorporation into 20 O.D. units of tRNA. 
Zero time incubation has been subtracted. 
0 
0 
0 
0 
0 
0 
30 min 60 min 120 min 240 min 
' 
2.8 2.9 3.4 --
3.2 5.6 -- --
0 0 0 --
0.6 0.7 0 0.4 
1.1 0 0 0 
0 0 0 0 
+:> 
w 
44 
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Fig. 3 Isopentenylpyrophosphate isomerase assays. 
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